North Adelaide, Australia

Robert Casson

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ellex Medical Pty Ltd. Active years: 2026.


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Robert Casson

Introduction

Robert Casson is an accomplished inventor based in North Adelaide, Australia. He is known for his significant contributions to the field of ophthalmic treatment. His innovative work focuses on developing devices that enhance the treatment of retinal diseases.

Latest Patents

Robert Casson holds a patent for a photobiomodulation device designed for treating retinal disease. This ophthalmic treatment device utilizes a treatment light source that produces a continuous wave or quasi-continuous wave output beam. The wavelength of the beam ranges from 600 nm to 1000 nm, with a power output between 1 mW and 500 mW. The device includes a beam homogenizing module, a beam shaping module, and a beam delivery and viewing module. This technology allows operators to deliver a treatment light beam to the retina with an intensity ranging from 1 mW/cm² to 500 mW/cm².

Career Highlights

Robert Casson is associated with Ellex Medical Pty Ltd, a company that specializes in developing innovative medical devices for the treatment of eye diseases. His work at Ellex Medical has positioned him as a key player in the advancement of ophthalmic technologies.

Collaborations

Robert has collaborated with notable colleagues, including Victor Previn and Wei Xia. Their combined expertise contributes to the development of cutting-edge solutions in the field of ophthalmology.

Conclusion

Robert Casson's innovative contributions to ophthalmic treatment through his patented photobiomodulation device exemplify his commitment to improving patient care. His work continues to influence the field of retinal disease treatment significantly.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…